Concepedia

Author

Ulrich Behre

University of Applied Sciences Kehl

Also Known As

Behre, Ulrich, U Behre, U. Behre, ULRICH BEHRE, Ulrich Behre

31

Publications

1.1K

Citations

17

H-Index

37

Concepts

All Affiliations

University of Applied Sciences KehlGlaxoSmithKline (Belgium)GlaxoSmithKline (India)GlaxoSmithKline (United Kingdom)Stiftung Juliusspital
UB

About

Ulrich Behre is an author at University of Applied Sciences Kehl specializing in medicine, vaccination, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

547

2

Immunology

11

11

366

3

Epidemiology

3

3

213

4

Public Health

2

2

54

5

Obstetrics

1

1

38

Ulrich Behre

×

23

Publications

1.1K

Citations

17

H-Index

YearCitations

Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial

James Hedrick, Asher Barzilai, Ulrich Behre,

The Pediatric Infectious Disease Journal

2000

244

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination

Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson,

Human Vaccines & Immunotherapeutics

2014

99

RotaTeq®, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe

Timo Vesikari, Robbin Itzler, Aino Karvonen,

Vaccine

2009

98

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study

Barbara Romanowski, Tino F. Schwarz, Linda Ferguson,

Human Vaccines & Immunotherapeutics

2015

93

Immunogenicity and Reactogenicity of Four Doses of Diphtheria-Tetanus-Three-Component Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae Type b Vaccine Coadministered with 7-Valent Pneumococcal Conjugate Vaccine

Irmingard Tichmann-Schumann, Peter Soemantri, Ulrich Behre,

The Pediatric Infectious Disease Journal

2005

88

Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years

Tino F. Schwarz, Li‐Min Huang, Doris Maribel Rivera Medina,

Journal of Adolescent Health

2012

56

Immunity to hepatitis B persists in adolescents 15–16 years of age vaccinated in infancy with three doses of hepatitis B vaccine

Olivier Van Der Meeren, Ulrich Behre, Priya Diana Crasta

Vaccine

2016

39

Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women

José García-Sicilia, Tino F. Schwarz, Alfonso Carmona,

Journal of Adolescent Health

2010

38

Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine

Yves Gillet, Gary Steri, Ulrich Behre,

Vaccine

2008

36

Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months

Markus Knuf, Fred Zepp, Claudius U. Meyer,

European Journal of Pediatrics

2010

36

Page 1